HELP     Sign In
Search

Relevance to Autism

This gene has been associated with syndromic autism, where a subpopulation of individuals with a given syndrome develop autism. In particular, studies have found rare mutations in the FOXG1 gene that are associated with FOXG1 syndrome (Kortm et al., 2011) and Rett's syndrome (quite a bit of phenotypic overlap exists between these two syndromes) as well as West syndrome.

Molecular Function

Transcription factor which plays an important role in the establishment of the regional subdivision of the developing brain and in the development of the telencephalon.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum h...
FOXG1 syndrome
Positive Association
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.
SCZ
Support
Gene Mutation Analysis in 253 Chinese Children with Unexplained Epilepsy and Intellectual/Developmental Disabilities.
DD, ID, epilepsy/seizures
Support
A 3 Mb deletion in 14q12 causes severe mental retardation, mild facial dysmorphisms and Rett-like features
Rett syndrome, congenital variant
Support
Identification of FOXG1 mutations in infantile hypotonia and postnatal microcephaly
DD
Epilepsy/seizures
Support
FOXG1 Mutation is a Low-Incidence Genetic Cause in Atypical Rett Syndrome
Rett syndrome, congenital variant
Support
FOXG1 mutations in Japanese patients with the congenital variant of Rett syndrome
Rett syndrome, congenital variant
Support
Behavioral and brain anatomical analysis of Foxg1 heterozygous mice
FOXG1 syndrome
Support
Cognition and Evolution of Movement Disorders of FOXG1-Related Syndrome.
Rett syndrome, congenital variant
Support
Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome.
DD
Support
Epilepsy/seizures
DD
Support
Additional chromosomal abnormalities in patients with a previously detected abnormal karyotype, mental retardation, and dysmorphic features
ID
Support
Autism spectrum disorder and comorbid neurodevelopmental disorders (ASD-NDDs): Clinical and genetic profile of a pediatric cohort
ASD
Epilepsy/seizures
Support
A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology.
ID, epilepsy, microcephaly
Support
A missense mutation within the fork-head domain of the forkhead box G1 Gene (FOXG1) affects its nuclear localization.
Rett syndrome, congenital variant
Support
Integrating de novo and inherited variants in 42
ASD
Support
Neurological Diseases With Autism Spectrum Disorder: Role of ASD Risk Genes.
ASD
ID
Support
Synaptic, transcriptional and chromatin genes disrupted in autism.
ASD
Support
DD
ASD, epilepsy/seizures
Support
Haploinsufficiency of novel FOXG1B variants in a patient with severe mental retardation, brain malformations and microcephaly
ID
Support
High prevalence of multilocus pathogenic variation in neurodevelopmental disorders in the Turkish population
DD
Support
Clinical exome sequencing: results from 2819 samples reflecting 1000 families.
Rett syndrome, congenital variant
DD, epilepsy/seizures, microcephaly
Support
Revisiting the phenotype associated with FOXG1 mutations: two novel cases of congenital Rett variant
Rett syndrome, congenital variant
Support
Behavioral Phenotypes of Foxg1 Heterozygous Mice
FOXG1 syndrome
Support
Early-onset movement disorder as diagnostic marker in genetic syndromes: Three cases of FOXG1-related syndrome.
FOXG1 syndrome
Support
De novo mutations in moderate or severe intellectual disability.
ID, epilepsy/seizures
Absent speech, microcephaly
Support
FoxG1 regulates the formation of cortical GABAergic circuit during an early postnatal critical period resulting in autism spectrum disorder-like phenotypes
ASD
Support
The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies.
DD, ID, epilepsy/seizures, microcephaly
Support
Atypical Rett syndrome with selective FOXG1 deletion detected by comparative genomic hybridization: case report and review of literature.
Rett syndrome, congenital variant
Support
Trio-based exome sequencing reveals a high rate of the de novo variants in intellectual disability
ASD, ID
Support
Hypoplastic hippocampus in atypical Rett syndrome with a novel FOXG1 mutation
Rett syndrome, congenital variant
Support
Novel mutation in forkhead box G1 (FOXG1) gene in an Indian patient with Rett syndrome
Rett syndrome, congenital variant
Support
DD, epilepsy/seizures
ASD
Support
Genetic and phenotypic analysis of 101 patients with developmental delay or intellectual disability using whole-exome sequencing
ASD, DD, epilepsy/seizures
Support
Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability
ID
Support
Novel FOXG1 mutations associated with the congenital variant of Rett syndrome
Rett syndrome, congenital variant
Support
Differential vulnerability of adult neurogenic niches to dosage of the neurodevelopmental-disorder linked gene Foxg1
Support
Using medical exome sequencing to identify the causes of neurodevelopmental disorders: experience of two clinical units and 216 patients.
ID
Microcephaly, hypotonia
Support
14q12 microdeletions excluding FOXG1 give rise to a congenital variant Rett syndrome-like phenotype.
Rett syndrome
DD, epilepsy
Support
Homozygous deletions implicate non-coding epigenetic marks in Autism spectrum disorder
ASD
Support
Comprehensive molecular testing in patients with high functioning autism spectrum disorder.
ASD
Support
Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females
Rett syndrome, congenital variant
Support
FOXG1 dose tunes cell proliferation dynamics in human forebrain progenitor cells
FOXG1 syndrome
Support
Genomic diagnosis for children with intellectual disability and/or developmental delay.
ASD, ID, epilepsy/seizures
Support
Analysis of FOXG1 Is Highly Recommended in Male and Female Patients with Rett Syndrome
Rett syndrome, congenital variant
Support
DD, epilepsy/seizures
Autistic features, stereotypy
Support
A case of congenital Rett variant in a Chinese patient caused by a FOXG1 mutation
Rett syndrome, congenital variant
DD, epilepsy/seizures, stereotypy
Highly Cited
Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures.
Highly Cited
FOXG1 is responsible for the congenital variant of Rett syndrome.
Rett syndrome
Highly Cited
Foxg1 suppresses early cortical cell fate.
Recent Recommendation
Imbalance of excitatory/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1 patients and in foxg1 mice.
Recent Recommendation
FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders.
Recent Recommendation
West syndrome associated with 14q12 duplications harboring FOXG1.
West syndrome
Recent Recommendation
The transcription factor Foxg1 regulates telencephalic progenitor proliferation cell autonomously, in part by controlling Pax6 expression levels.
Recent Recommendation
FOXG1 syndrome: genotype-phenotype association in 83 patients with FOXG1 variants.
Rett syndrome, congenital variant

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN094R001 
 stop_gained 
 c.765G>A 
 p.Trp255Ter 
 De novo 
  
  
 GEN094R002 
 frameshift_variant 
 c.969del 
 p.Ser323ArgfsTer3 
 De novo 
  
  
 GEN094R003 
 copy_number_gain 
  
  
 De novo 
  
  
 GEN094R004 
 copy_number_gain 
  
  
 De novo 
  
  
 GEN094R005 
 translocation 
  
  
 De novo 
  
  
 GEN094R006 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN094R007 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN094R008 
 copy_number_loss 
  
  
  
  
  
 GEN094R009 
 missense_variant 
 c.757A>G 
 p.Asn253Asp 
 De novo 
  
  
 GEN094R010 
 frameshift_variant 
 c.460dup 
 p.Glu154GlyfsTer301 
 De novo 
  
  
 GEN094R011 
 frameshift_variant 
 c.505_506delinsT 
 p.Gly169SerfsTer23 
 De novo 
  
  
 GEN094R012 
 frameshift_variant 
 c.460dup 
 p.Glu154GlyfsTer301 
  
  
  
 GEN094R013 
 stop_gained 
 c.256C>T 
 p.Gln86Ter 
  
  
  
 GEN094R014 
 frameshift_variant 
 c.263_278del 
 p.Arg88ProfsTer99 
 De novo 
  
  
 GEN094R015 
 missense_variant 
 c.700T>C 
 p.Ser234Pro 
 De novo 
  
  
 GEN094R016 
 frameshift_variant 
 c.256dup 
 p.Gln86ProfsTer35 
 De novo 
  
 Unknown 
 GEN094R017 
 stop_gained 
 c.738C>A 
 p.Tyr246Ter 
 De novo 
  
 Simplex 
 GEN094R018a 
 missense_variant 
 c.1139C>T 
 p.Thr380Met 
 De novo 
  
  
 GEN094R018b 
 synonymous_variant 
 c.1146C>G 
 p.Ala382%3D 
 De novo 
  
  
 GEN094R019 
 missense_variant 
 c.1241C>A 
 p.Thr414Asn 
 De novo 
  
  
 GEN094R020 
 missense_variant 
 c.1456C>T 
 p.Pro486Ser 
 Familial 
 Maternal 
 Simplex 
 GEN094R021 
 missense_variant 
 c.565C>G 
 p.Leu189Val 
 Unknown 
 Not maternal 
  
 GEN094R022 
 missense_variant 
 c.730C>T 
 p.Arg244Cys 
 De novo 
  
  
 GEN094R023 
 stop_gained 
 c.385G>T 
 p.Glu129Ter 
 De novo 
  
 Simplex 
 GEN094R024 
 translocation 
  
  
 De novo 
  
  
 GEN094R025 
 complex_structural_alteration 
  
  
 De novo 
  
  
 GEN094R026 
 complex_structural_alteration 
  
  
 De novo 
  
  
 GEN094R027 
 translocation 
  
  
 De novo 
  
  
 GEN094R028 
 missense_variant 
 c.673T>C 
 p.Trp225Arg 
 De novo 
  
  
 GEN094R029 
 frameshift_variant 
 c.506del 
 p.Gly169AlafsTer23 
 De novo 
  
 Simplex 
 GEN094R030 
 missense_variant 
 c.553A>T 
 p.Ser185Cys 
 De novo 
  
  
 GEN094R031 
 missense_variant 
 c.821G>A 
 p.Arg274Gln 
 De novo 
  
  
 GEN094R032 
 frameshift_variant 
 c.460del 
 p.Glu154ArgfsTer38 
 De novo 
  
  
 GEN094R033 
 frameshift_variant 
 c.256del 
 p.Gln86ArgfsTer106 
 De novo 
  
  
 GEN094R034 
 stop_gained 
 c.214C>T 
 p.Gln72Ter 
 De novo 
  
  
 GEN094R035 
 stop_gained 
 c.406G>T 
 p.Glu136Ter 
 De novo 
  
  
 GEN094R036 
 frameshift_variant 
 c.460dupG 
 p.Glu154GlyfsTer301 
 De novo 
  
  
 GEN094R037 
 frameshift_variant 
 c.385del 
 p.Glu129SerfsTer63 
 De novo 
  
  
 GEN094R038 
 frameshift_variant 
 c.460del 
 p.Glu154ArgfsTer38 
 De novo 
  
  
 GEN094R039 
 frameshift_variant 
 c.460dup 
 p.Glu154GlyfsTer301 
 Unknown 
  
  
 GEN094R040 
 frameshift_variant 
 c.460dup 
 p.Glu154GlyfsTer301 
 De novo 
  
  
 GEN094R041 
 frameshift_variant 
 c.460dup 
 p.Glu154GlyfsTer301 
 De novo 
  
  
 GEN094R042 
 stop_gained 
 c.517G>T 
 p.Glu173Ter 
 De novo 
  
  
 GEN094R043 
 missense_variant 
 c.543G>C 
 p.Lys181Asn 
 De novo (germline mosaicism) 
  
 Multiplex 
 GEN094R044 
 missense_variant 
 c.545C>A 
 p.Pro182Gln 
 De novo 
  
  
 GEN094R045 
 missense_variant 
 c.553A>T 
 p.Ser185Cys 
 De novo 
  
  
 GEN094R046 
 missense_variant 
 c.561C>A 
 p.Asn187Lys 
 De novo 
  
  
 GEN094R047 
 missense_variant 
 c.561C>A 
 p.Asn187Lys 
 De novo 
  
  
 GEN094R048 
 missense_variant 
 c.565C>T 
 p.Leu189Phe 
 De novo 
  
 Multiplex (monozygotic twins) 
 GEN094R049 
 missense_variant 
 c.581T>G 
 p.Ile194Ser 
 De novo 
  
  
 GEN094R050 
 inframe_deletion 
 c.592_594del 
 p.Pro198del 
 De novo 
  
  
 GEN094R051 
 frameshift_variant 
 c.611_618del 
 p.Leu204HisfsTer248 
 De novo 
  
  
 GEN094R052 
 stop_gained 
 c.624C>G 
 p.Tyr208Ter 
 De novo 
  
  
 GEN094R053 
 missense_variant 
 c.730C>T 
 p.Arg244Cys 
 De novo 
  
  
 GEN094R054 
 frameshift_variant 
 c.732_741del 
 p.His245ThrfsTer78 
 De novo 
  
  
 GEN094R055 
 frameshift_variant 
 c.974dup 
 p.Leu325PhefsTer130 
 De novo 
  
  
 GEN094R056 
 frameshift_variant 
 c.1082dup 
 p.Leu362ProfsTer93 
 De novo 
  
  
 GEN094R057 
 frameshift_variant 
 c.1141del 
 p.Ala381ProfsTer4 
 De novo 
  
  
 GEN094R058 
 missense_variant 
 c.755G>A 
 p.Gly252Asp 
 De novo 
  
  
 GEN094R059 
 stop_gained 
 c.921C>G 
 p.Tyr307Ter 
 De novo 
  
  
 GEN094R060 
 missense_variant 
 c.590G>T 
 p.Ser197Ile 
 De novo 
  
  
 GEN094R061 
 missense_variant 
 c.545C>T 
 p.Pro182Leu 
 De novo 
  
  
 GEN094R062 
 copy_number_loss 
  
  
 Unknown 
  
 Simplex 
 GEN094R063 
 frameshift_variant 
 c.392del 
 p.Gly131AlafsTer61 
 Unknown 
  
 Simplex 
 GEN094R064 
 copy_number_loss 
  
  
 De novo 
  
 Simplex 
 GEN094R065 
 stop_gained 
 c.1188C>A 
 p.Cys396Ter 
 De novo 
  
  
 GEN094R066 
 missense_variant 
 c.763T>C 
 p.Trp255Arg 
 Unknown 
  
  
 GEN094R067 
 frameshift_variant 
 c.256del 
 p.Gln86ArgfsTer106 
 Unknown 
  
  
 GEN094R068 
 frameshift_variant 
 c.256dup 
 p.Gln86ProfsTer35 
 Unknown 
  
  
 GEN094R069 
 frameshift_variant 
 c.506dup 
 p.Lys170GlnfsTer285 
 De novo 
  
 Simplex 
 GEN094R070a 
 copy_number_loss 
  
  
 Familial 
 Both parents 
  
 GEN094R071 
 frameshift_variant 
 c.506del 
 p.Gly169AlafsTer23 
 De novo 
  
 Simplex 
 GEN094R072 
 stop_gained 
 c.651C>G 
 p.Tyr217Ter 
 De novo 
  
 Simplex 
 GEN094R073 
 stop_gained 
 c.1188C>A 
 p.Cys396Ter 
 De novo 
  
  
 GEN094R074 
 missense_variant 
 c.761A>C 
 p.Tyr254Ser 
 De novo 
  
 Simplex 
 GEN094R075 
 frameshift_variant 
 c.958del 
 p.Arg320AlafsTer6 
 De novo 
  
 Simplex 
 GEN094R076 
 frameshift_variant 
 c.506dup 
 p.Lys170GlnfsTer285 
 De novo 
  
 Simplex 
 GEN094R077 
 frameshift_variant 
 c.479_488del 
 p.Gly160AlafsTer29 
 De novo 
  
  
 GEN094R078 
 missense_variant 
 c.752A>G 
 p.Lys251Arg 
 De novo 
  
  
 GEN094R079 
 missense_variant 
 c.770T>G 
 p.Leu257Arg 
 De novo 
  
 Simplex 
 GEN094R080 
 missense_variant 
 c.934C>A 
 p.Pro312Thr 
 De novo 
  
  
 GEN094R081 
 stop_gained 
 c.385G>T 
 p.Glu129Ter 
 De novo 
  
 Simplex 
 GEN094R082 
 missense_variant 
 c.673T>G 
 p.Trp225Gly 
 Unknown 
  
 Simplex 
 GEN094R083 
 stop_gained 
 c.624C>A 
 p.Tyr208Ter 
 Unknown 
  
 Simplex 
 GEN094R084 
 frameshift_variant 
 c.479_488del 
 p.Gly160AlafsTer29 
 De novo 
  
  
  et al.  
 GEN094R085 
 missense_variant 
 c.584G>C 
 p.Arg195Pro 
 De novo 
  
  
  et al.  
 GEN094R086 
 frameshift_variant 
 c.314_335del 
 p.Pro105ArgfsTer80 
 De novo 
  
  
  et al.  

Common

Variant ID
Polymorphism
SNP ID
Allele Change
Residue Change
Population Origin
Population Stage
Author, Year
 GEN094C001 
 intergenic_variant 
 rs10148671 
 T>C 
  
 40,675 SCZ cases and 64,643 controls (CLOZUK and independent PGC datasets) 
 Discovery 
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
14
Duplication
 1
 
14
Duplication
 4
 
14
Duplication
 1
 
14
Deletion
 2
 
14
Deletion
 1
 
14
Deletion-Duplication
 22
 
14
Deletion
 1
 

Model Summary

Important role for Foxg1 in cortical development, reveal noteworthy complexity in the invocation of specific mechanisms underlying phenotypes.

References

Type
Title
Author, Year
Primary
Disruption of Foxg1 expression by knock-in of cre recombinase: effects on the development of the mouse telencephalon.
additional
FoxG1 regulates the formation of cortical GABAergic circuit during an early postnatal critical period resulting in autism spectrum disorder-like phenotypes
Additional
Behavioral Phenotypes of Foxg1 Heterozygous Mice
additional
Winged helix transcription factor BF-1 is essential for the development of the cerebral hemispheres

M_FOXG1_1_KO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Foxg1-Cre knock-in/knock-out mice express Cre recombinase from the endogenous Foxg1 locus.
Allele Type: Knockout
Strain of Origin: 129P2/OlaHsd-Hprt^b-m3
Genetic Background: C57BL/6J
ES Cell Line: HM-1
Mutant ES Cell Line:
Model Source: Jackson Laboratory

M_FOXG1_2_CKO_HT-GG-LOW

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Foxg1 low models were generated by crossing male nex-cre4; dlx-cre animals with female foxg1-c/c; r26-cag-frted stop-egfp homozygous animals (rce:frt, jackson laboratories stock #10812). upon cre-mediated recombination, the conditional floxed-foxg1 allele is converted into a flpe knock-in allele, and thus the recombination efficiency in each animal can be evaluated by egfp expression from the flp-dependent egfp reporter rce:frt. the conditional floxed ready foxg1 allele has loxp sites inserted to flank the foxg1 coding sequence. this model preserves foxg1 expression in neural progenitors and glial cells and selectively deletes foxg1 in postmitotic glutamatergic (nex-cre) and gabaergic (dlx-cre) neurons of the forebrain.
Allele Type: Conditional knockout
Strain of Origin: Not reported
Genetic Background: Not reported
ES Cell Line:
Mutant ES Cell Line:
Model Source: Miyoshi et al, 2010; Miyoshi, et al, 2012, 22726835

M_FOXG1_2_KO_HT

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: A null mutation of foxg1 was generated by replacing 2.3kb of coding sequence with a lacz and neomycin cassette
Allele Type: Knockout
Strain of Origin: 129S1/Sv-Oca2+ Tyr+ Kitl+
Genetic Background: C57BL/6J
ES Cell Line: CJ7 (ES Cell)
Mutant ES Cell Line: CJ7 (ES Cell)
Model Source: Xuan et al, 1995; 7605629

M_FOXG1_2_KO_HT_GABA

Model Type: RESCUE-Transplantation
Model Genotype: Heterozygous
Mutation: Augmentation of gabaergic systems during the juvenile critical period, 1-2 weeks, was accompilshed in the foxg1 het model by gabaergic cell precursor transplantation into the mpfc. dissociated egfp-labeled gabaergic cell precursors (dlx-cre; rce:loxp59,60) from the e13.5 medial ganglionic eminences (mge) that are wild type for foxg1, were bilaterally transplanted into the postnatal 1 week medial prefrontal cortices, and e/i ratios analyzed at 2 weeks. miniature frequencies of mpfc layer 2/3 cells were analyzed one week after the transplantation.
Allele Type: Knockout
Strain of Origin: 129S1/Sv-Oca2+ Tyr+ Kitl+
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source: 7605629

M_FOXG1_3_CKO_HT-GLU-LOW

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Foxg1 glu-low models were generated by crossing male nex-cre4; animals with female foxg1-c/c; r26-cag-frted stop-egfp homozygous animals (rce:frt, jackson laboratories stock #10812). upon cre-mediated recombination, the conditional floxed-foxg1 allele is converted into a flpe knock-in allele, and thus the recombination efficiency in each animal can be evaluated by egfp expression from the flp-dependent egfp reporter rce:frt. the conditional floxed ready foxg1 allele has loxp sites inserted to flank the foxg1 coding sequence. this model preserves foxg1 expression in neural progenitors and glial cells and selectively deletes foxg1 in postmitotic glutamatergic (nex-cre).
Allele Type: Conditional knockout
Strain of Origin: Not reported
Genetic Background: Not reported
ES Cell Line:
Mutant ES Cell Line:
Model Source: Miyoshi et al, 2010; Miyoshi, et al, 2012, 22726835

M_FOXG1_4_CKO_HT-GABA-LOW

Model Type: Genetic LOF
Model Genotype: Heterozygous
Mutation: Foxg1 gaba- low models were generated by crossing male dlx-cre animals with female foxg1-c/c; r26-cag-frted stop-egfp homozygous animals (rce:frt, jackson laboratories stock #10812). upon cre-mediated recombination, the conditional floxed-foxg1 allele is converted into a flpe knock-in allele, and thus the recombination efficiency in each animal can be evaluated by egfp expression from the flp-dependent egfp reporter rce:frt. the conditional floxed ready foxg1 allele has loxp sites inserted to flank the foxg1 coding sequence. this model preserves foxg1 expression in neural progenitors and glial cells and selectively deletes foxg1 in postmitotic gabaergic (dlx-cre) neurons of the forebrain.
Allele Type: Conditional knockout
Strain of Origin: Not reported
Genetic Background: Not reported
ES Cell Line:
Mutant ES Cell Line:
Model Source: Miyoshi et al, 2010; Miyoshi, et al, 2012, 22726835

M_FOXG1_5_CKO_HT-GG-HIGH-1

Model Type: Genetic GOF
Model Genotype: Heterozygous
Mutation: Foxg1 high models were generated by crossing male nex-cre; dlx-cre animals to female r26-stop-tta homozygous (conditional transactivator; jackson laboratories stock #008600); tre-foxg1 homozygous animals. tre-foxg1, a foxg1 expression allele contains an ires-lacz cassette downstream of the foxg1 coding sequence so that foxg1 gof population can be visualized based on x-gal staining. since foxg1 gain-of-function can disrupt migration of pyramidal neurons, foxg1 expression is augmented during the early postnatal period after most neuronal migration is complete (~1st postnatal week; p7). to delay foxg1 augmentation until after postnatal 1 week, a doxycycline-containing diet (200 ppm, #1810413 test diet) was provided to the pregnant females from the date of the observed plug until postnatal day 7.
Allele Type: Conditional knockout
Strain of Origin: Not reported
Genetic Background: Not reported
ES Cell Line:
Mutant ES Cell Line:
Model Source: Miyoshi et al, 2010; Miyoshi, et al, 2012, 22726835

M_FOXG1_3_KO_HM

Model Type: Genetic LOF
Model Genotype: Homozygous
Mutation: A null mutation of foxg1 was generated by replacing 2.3kb of coding sequence with a lacz and neomycin cassette. heterozygotes are indistinguishable from wild-type littermates, except by the expression of beta-gal.
Allele Type: Knockout
Strain of Origin: 129S1/Sv-Oca2+ Tyr+ Kitl+
Genetic Background: C57BL/6J
ES Cell Line: CJ7 (ES Cell)
Mutant ES Cell Line: CJ7 (ES Cell)
Model Source: Xuan et al, 1995; 7605629

M_FOXG1_1_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity: ambulatory activity2
Increased
Description: Foxg1 heterozygous mice exhibited higher activity levels and greater distance moved compared to wildtype mice.
 Open field test
 7 weeks
Motor strength and endurance2
Decreased
Description: Foxg1 heterozygous mice displayed lower reach scores compared to wildtype mice, with no sex differences among mutant mice; reach scores of Foxg1 heterozygous mice improved much less with training and reached a plateau below 2; latency to reach was also greater in mutant mice.
 Wire hang test
 7 weeks
Brain size1
Decreased
Description: Decreased volume of posencephalon reflecting alterations in volume of telencephalic structures
Exp Paradigm: Magnetic resonance microscopy of intact male brains
 Magnetic resonance imaging (mri)
 Unreported
Somatosensory cortical map architecture1
Decreased
Description: Decreased area of cortical sheet, barrel field size and individual barrels with a pronounced rostral effect
Exp Paradigm: Immunohistochemistry
 Immunohistochemistry
 P8
Brain development1
Abnormal
Description: Abnormal brain development indicated by abnormal representation of neurons in cortex
Exp Paradigm: In situ hybridization and immunocytochemistry using markers against specific layers in cortex
 In situ hybridization (ish)
 E16.5, p4
Neuronal number: purkinje cells1
Decreased
Description: Decreased total number of gad-67 positive interneurons in mutant cortex
Exp Paradigm: Immunohistochemistry using anti gad 67 antibodies
 Immunohistochemistry
 Unreported
Brain anatomy1
Decreased
Description: Decreased dimension of cerebral hemisphere demonstrated by decreased medio-lateral and midline anterior-posterior length
Exp Paradigm: Magnetic resonance microscopy (mrm) of fixed tissue
 Magnetic resonance imaging (mri)
 P4
Cortical thickness1
Decreased
Description: Decreased cortical thickness in supragranular (i-iii), granular (iv) and infragranular (v-vi) layers along with decreased total number of cells
Exp Paradigm: Photomicrographic analysis of co stained coronal sections
 Photomicrographic analysis
 Unreported
Thalamic morphology1
Decreased
Description: Decreased thalamic volume along with reduction in total number of cells in ventrobasal complex of thalamus
Exp Paradigm: Magnetic resonance microscopy of sagittal sections; cell counting of nissl-stained section
 Magnetic resonance imaging (mri)
 Unreported
Pain or nociception2
Increased
Description: On the training day, there was no genotype difference in activity or percent freezing during the baseline period; Foxg1 heterozygous mice showed an increased response to the shocks average motion during the shocks.
 Fear conditioning test
 7 weeks
Exploratory activity2
Increased
Description: Female Foxg1 mutant mice entered more arms in the Y-maze compared to sex-matched wildtype mice.
 Y-maze test
 7 weeks
Anxiety2
Increased
Description: Foxg1 heterozygous mice spent less time in the anxiety-provoking center of the open field than wildtype mice; females spent more time in the center of the open field than males.
 Open field test
 7 weeks
Cued or contextual fear conditioning: memory of context2
Decreased
Description: Foxg1 heterozygous mice showed dramatically reduced freezing in the contextual fear memory test.
 Fear conditioning test
 7 weeks
Cued or contextual fear conditioning2
Decreased
Description: On the training day, Foxg1 heterozygous mice showed reduced freezing between the two tone-shock interval, indicating reduced acquisition of fear.
 Fear conditioning test
 7 weeks
Object recognition memory2
Decreased
Description: Foxg1 heterozygous mice displayed a smaller discrimination index than wildtype mice.
 Novel object recognition test
 7 weeks
Cued or contextual fear conditioning: memory of cue2
Decreased
Description: Foxg1 heterozygous mice froze less than wildtype mice across the pre-tone and tone periods.
 Fear conditioning test
 7 weeks
Exploratory activity2
 No change
 Y-maze test
 7 weeks
Exploratory activity2
 No change
 Novel object recognition test
 7 weeks
Exploratory activity: habituation2
 No change
 Open field test
 7 weeks
Spatial working memory2
 No change
 Y-maze test
 7 weeks
Thalamic morphology1
 No change
 Magnetic resonance imaging (mri)
 P4
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_FOXG1_2_CKO_HT-GG-LOW

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Miniature post synaptic current frequency: excitatory1
Increased
Description: Increase in mepsc frequency
 Whole-cell patch clamp
 2 weeks
Miniature post synaptic current amplitude: inhibitory1
Increased
Description: Increased mipsc amplitude
 Whole-cell patch clamp
 2 weeks
Electroencephalogram (EEG) signature1
Abnormal
Description: Peak amplitude reduced in the low model; overall reduction in high-gamma frequency power (55â??80 hz)
 Electroencephalogram (EEG)
 8 weeks
Synaptic transmission1
Abnormal
Description: Altered e/i mepsc to mipsc frequency but not amplitude ratio within the medial prefrontal cortex; mepsc and mipsc measured in layer 2/3 pyramidal neurons of the medial prefrontal cortex (prelimbic and infralimbic)
 Whole-cell patch clamp
 2 weeks
Social memory1
Decreased
Description: Decrease in preference for novel social stimulus over familiar social stimulus
 Three-chamber social approach test
 6 weeks
Social approach1
Decreased
Description: Decrease in social preference similar to pan het model
 Three-chamber social approach test
 6 weeks
Targeted expression1
Decreased
Description: Foxg1 protein levels within the medial prefrontal cortex at postnatal 2 and 6 weeks by western blotting reduced to half; foxg1 protein levels change 2 days upon addition or removal of the doxycycline-containing diet
 Western blot
 2-6 weeks
Anxiety1
 No change
 Open field test
 Adult
Anxiety1
 No change
 Elevated plus maze test
 Adult
Spatial working memory1
 No change
 Eight-arm radial maze test
 6 weeks
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 2 weeks
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current amplitude: inhibitory1
 No change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current frequency: excitatory1
 No change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current frequency: inhibitory1
 No change
 Whole-cell patch clamp
 2 weeks
Miniature post synaptic current frequency: inhibitory1
 No change
 Whole-cell patch clamp
 Adult
Synaptic transmission1
 No change
 Whole-cell patch clamp
 Adult
Seizures1
 No change
 Electroencephalogram (EEG)
 8 weeks
Aggression1
 No change
 Home cage behavior
 Not reported
 Not Reported:

M_FOXG1_2_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Neuronal number: Inhibitory neurons2
Decreased
Description: Reduced gad1 positive gabaergic cell numbers in the pfc and barrel cortex
 Histology
 P21
Brain size2
Decreased
Description: Reduction in the size of the cerebral hemispheres
 Histology
 P21
Brain development1
Abnormal
Description: Development of the ventral telencephalon is more severely affected than that of the dorsal telencephalon
 In situ hybridization (ISH)
 E9.5-P0
Synaptic transmission2
Decreased
Description: Decreased e/i frequency but not amplitude ratio within the adult medial prefrontal cortex in foxg1 asd models
 Whole-cell patch clamp
 Adult
Miniature post synaptic current frequency: excitatory2
Increased
Description: Increase in mepsc frequency
 Whole-cell patch clamp
 2 weeks
Miniature post synaptic current frequency: excitatory2
Decreased
Description: Decrease in mepsc frequency
 Whole-cell patch clamp
 Adult
Synaptic transmission2
Decreased
Description: Decreased e/i mepsc to mipsc frequency but not amplitude ratio within the medial prefrontal cortex; mepsc and mipsc measured in layer 2/3 pyramidal neurons of the medial prefrontal cortex (prelimbic and infralimbic); no change in the barrel cortex
 Whole-cell patch clamp
 2 weeks
Electroencephalogram (EEG) signature2
Abnormal
Description: Peak of gamma-band frequency of eeg in awake free-moving state with the electrodes aligned nearby the medial prefrontal cortex was reduced and shifted to a lower frequency range; overall reduction in high-gamma frequency power (55â??80 hz)
 Electroencephalogram (EEG)
 8 weeks
Social approach2
Decreased
Description: No preference for the social side of the chamber
 Three-chamber social approach test
 6 weeks
Aggression2
Increased
Description: Heterozygous animals are often aggressive, and attack siblings or partners during mating
 Home cage behavior
 Not reported
Social memory2
Decreased
Description: Increase in time spent in the empty chamber, indicating no preference for social novelty
 Three-chamber social approach test
 6 weeks
Anxiety2
Decreased
Description: Increased time in the center
 Open field test
 6 weeks
Anxiety2
Decreased
Description: Increased time in open arms
 Elevated plus maze test
 6 weeks
Spatial working memory2
Decreased
Description: Impaired spatial working memory
 Eight-arm radial maze test
 6 weeks
Targeted expression2
Decreased
Description: Foxg1 protein levels within the medial prefrontal cortex at postnatal 2 and 6 weeks by western blotting reduced to half
 Western blot
 2-6 weeks
Mortality/lethality1
 No change
 General observations
 P0-adult
General locomotor activity: Ambulatory activity2
 No change
 Open field test
 6 weeks
Cortical thickness2
 No change
 Histology
 P21
Miniature post synaptic current amplitude: excitatory2
 No change
 Whole-cell patch clamp
 2 weeks
Miniature post synaptic current amplitude: excitatory2
 No change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current amplitude: inhibitory2
 No change
 Whole-cell patch clamp
 2 weeks
Miniature post synaptic current amplitude: inhibitory2
 No change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current frequency: inhibitory2
 No change
 Whole-cell patch clamp
 2 weeks
Miniature post synaptic current frequency: inhibitory2
 No change
 Whole-cell patch clamp
 Adult
Reproductive function1
 No change
 Genotypic ratio of progeny from heterozygous parents
 Adult
Seizures2
 No change
 Electroencephalogram (EEG)
 8 weeks
 Not Reported:

M_FOXG1_2_KO_HT_GABA

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Synaptic transmission1
Restored
Description: Increased e/i ratio in the heterozygous animals was rescued to wild type level
 Whole-cell patch clamp
 2 weeks, Adult
Social memory1
Restored
Description: Decreased unfamiliar social preference in the het mutants was rescued to wildtype levels
 Three-chamber social approach test
 6 weeks
Social approach1
Restored
Description: Decreased social preference in the het mutants was rescued to wildtype levels
 Three-chamber social approach test
 6 weeks
Spatial working memory1
Refractory
Description: No improvement in spatial working memory
 Eight-arm radial maze test
 6 weeks
 Not Reported:

M_FOXG1_3_CKO_HT-GLU-LOW

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Electroencephalogram (EEG) signature1
Abnormal
Description: Peak amplitude reduced in the low model; overall reduction in high-gamma frequency power (55â??80 hz)
 Electroencephalogram (EEG)
 8 weeks
Targeted expression1
Decreased
Description: Foxg1 protein levels within the medial prefrontal cortex at postnatal 2 and 6 weeks by western blotting reduced to half; foxg1 protein levels change 2 days upon addition or removal of the doxycycline-containing diet
 Western blot
 2-6 weeks
Anxiety1
 No change
 Open field test
 Adult
Anxiety1
 No change
 Elevated plus maze test
 Adult
Spatial working memory1
 No change
 Eight-arm radial maze test
 6 weeks
Seizures1
 No change
 Electroencephalogram (EEG)
 8 weeks
Aggression1
 No change
 Home cage behavior
 Not reported
Social approach1
 No change
 Three-chamber social approach test
 6 weeks
Social memory1
 No change
 Three-chamber social approach test
 6 weeks
 Not Reported:

M_FOXG1_4_CKO_HT-GABA-LOW

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Neuronal number: Inhibitory neurons1
Decreased
Description: Reduced gad1 positive gabaergic cell numbers in the pfc and barrel cortex
 Histology
 P21
Electroencephalogram (EEG) signature1
Abnormal
Description: Peak amplitude reduced in the low model; overall reduction in high-gamma frequency power (55â??80 hz)
 Electroencephalogram (EEG)
 8 weeks
Social memory1
Increased
Description: Increased preference for social novelty
 Three-chamber social approach test
 6 weeks
Targeted expression1
Decreased
Description: Foxg1 protein levels within the medial prefrontal cortex at postnatal 2 and 6 weeks by western blotting reduced to half; foxg1 protein levels change 2 days upon addition or removal of the doxycycline-containing diet
 Western blot
 2-6 weeks
Anxiety1
 No change
 Open field test
 Adult
Anxiety1
 No change
 Elevated plus maze test
 Adult
Spatial working memory1
 No change
 Eight-arm radial maze test
 6 weeks
Cortical thickness1
 No change
 Histology
 P21
Seizures1
 No change
 Electroencephalogram (EEG)
 8 weeks
Aggression1
 No change
 Home cage behavior
 Not reported
Social approach1
 No change
 Three-chamber social approach test
 6 weeks
 Not Reported:

M_FOXG1_5_CKO_HT-GG-HIGH-1

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Miniature post synaptic current frequency: excitatory1
Increased
Description: Increased mepsc frequency
 Whole-cell patch clamp
 2 weeks
Miniature post synaptic current amplitude: excitatory1
Decreased
Description: Decreased mepsc amplitude
 Whole-cell patch clamp
 2 weeks
Electroencephalogram (EEG) signature1
Abnormal
Description: Peak shifted to lower frequency in the high model; overall reduction in high-gamma frequency power (55â??80 hz)
 Electroencephalogram (EEG)
 8 weeks
Miniature post synaptic current frequency: inhibitory1
Increased
Description: Increased mipsc frequency
 Whole-cell patch clamp
 2 weeks
Social memory1
Decreased
Description: Animals exhibit social novelty deficits only when foxg1 is augmented in both glu+gaba lineages simultaneously; milder than pan het phenotype
 Three-chamber social approach test
 6 weeks
Social approach1
Decreased
Description: Animals exhibit social approach deficits only when foxg1 is augmented in both glu+gaba lineages simultaneously; milder phenotype than pan het and gg-low
 Three-chamber social approach test
 6 weeks
Targeted expression1
Increased
Description: Foxg1 protein levels within the medial prefrontal cortex at postnatal 2 weeks increased; increase of foxg1 protein is suppressed by continuous feeding of doxycycline; foxg1 protein levels change 2 days upon addition or removal of the doxycycline-containing diet
 Western blot
 2 weeks
Anxiety1
 No change
 Open field test
 Adult
Anxiety1
 No change
 Elevated plus maze test
 Adult
Spatial working memory1
 No change
 Eight-arm radial maze test
 6 weeks
Miniature post synaptic current amplitude: excitatory1
 No change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current amplitude: inhibitory1
 No change
 Whole-cell patch clamp
 2 weeks
Miniature post synaptic current amplitude: inhibitory1
 No change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current frequency: excitatory1
 No change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current frequency: inhibitory1
 No change
 Whole-cell patch clamp
 Adult
Synaptic transmission1
 No change
 Whole-cell patch clamp
 2 weeks
Synaptic transmission1
 No change
 Whole-cell patch clamp
 Adult
Seizures1
 No change
 Electroencephalogram (EEG)
 8 weeks
Aggression1
 No change
 Home cage behavior
 Not reported
 Not Reported:

M_FOXG1_3_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Spontaneous Movement1
Decreased
Description: Minimal spontaneous movement
 General observations
 P0
Neocortex morphology1
Abnormal
Description: Reduction in the size of the cerebral hemispheres, irregular, uneven cerebral cortex
 Gross necroscopy
 E9.5-P0
Brain development1
Abnormal
Description: Development of the ventral telencephalon is more severely affected than that of the dorsal telencephalon
 In situ hybridization (ISH)
 E9.5-P0
Size of cerebral ventricles1
Decreased
Description: Progressive reduction in the size of the telencephalic vesicles
 In situ hybridization (ISH)
 E10.5-E14.5
Morphology of telencephalon1
Abnormal
Description: Abnormal morphogenesis of the telencephalon, dorsal telencephalic vesicles of the are positioned more ventrally and closer to the level of the eyes; dorsal telencephalon is reduced in size, the ventral telencephalon is almost completely absent; mutant tissue that expressed the beta-gal is negative for the expression of the dorsal telencephalic markers, emx2 and pax6
 In situ hybridization (ISH)
 E9.5-P0
Olfactory bulb morphology1
Decreased
Description: Olfactory bulbs were markedly reduced in size
 Gross necroscopy
 P0
Cortical thickness1
Decreased
Description: Variable thickness
 Histology
 E12.5
Neuronal differentiation1
Decreased
Description: Almost all of the telencephalic neuroepithelium at e12.5 expressed the dorsal markers emx2, neither ventral marker, dix2 and dix 1 were expressed in the telencephalic neuroepithelium; dorsal telencephalic neuroepithelial cells also differentiate prematurely; early withdrawal of telencephalic neuroepithelial cells from the cell cycle and in the premature onset of neuronal differentiation.
 Immunohistochemistry
 E12.5
Cell proliferation: neural precursors1
Decreased
Description: Reduced proliferation of telencephalic neuroepithelial cells , no significant differences were observed in the brdu labeling patterns of mutant and wild-type embryos at e9.5; decreased brdu-labeled cells in both dorsal and ventral regions of the mutant telencephalon at e10.5, early depletion of neural progenitor population; absence of ventral telencephaion primarily due to the failure of precursor cells in this region to continue proliferating actively after e9.5
 Immunohistochemistry
 E9.5-E10.5
Mortality/lethality: neonatal1
Increased
Description: Increased neonatal lethality, most die at birth, cyanotic, death was due to respiratory failure
 General observations
 P0-P21
General characteristics1
Abnormal
Description: Newborns were flaccid
 General observations
 P0
Eye development1
Abnormal
Description: Abnormalities of the eyes, eyes of newborns were distorted in shape, being ellipsoid
 General observations
 P0
Skeletal development: craniofacial1
Abnormal
Description: Flattening of the frontal skull
 General observations
 P0
Developmental trajectory1
Abnormal
Description: Differences between mutant and wild-type embryo morphology became progressively more apparent as development proceeded
 In situ hybridization (ISH)
 E9.5-P0
Brain morphology1
 No change
 Gross necroscopy
 E10.5-E14.5
Neuronal specification1
 No change
 Histology
 E9.5-P0
Neuronal apoptosis1
 No change
 Histology
 E9.5-P0
 Not Reported:


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
AR androgen receptor 367 P10275 Y2H; GST; Luciferase reporter assay
Obendorf M , et al. 2007
EEF1G eukaryotic translation elongation factor 1 gamma 1937 P26641 Y2H
Stelzl U , et al. 2005
FMR1 fragile X mental retardation 1 2332 G8JLE9 PAR-CLIP; RNA immunoprecipitation (RIP)
Ascano M Jr , et al. 2012
FOXO3 forkhead box O3 2309 O43524 IP/WB
Seoane J , et al. 2004
FOXP1 forkhead box P1 27086 Q9H334 ChIP-Seq
Vitezic M , et al. 2014
GDF9 growth differentiation factor 9 2661 O60383 Y2H
Stelzl U , et al. 2005
KDM5B lysine (K)-specific demethylase 5B 10765 Q9UGL1 Y2H; Luciferase reporter assay; IP/WB
Tan K , et al. 2003
MECP2 methyl CpG binding protein 2 (Rett syndrome) 4204 P51608 IP/WB
Dastidar SG , et al. 2012
NFY Nuclear transcription factor Y subunit alpha 4800 P23511 ChIP-Seq
Vitezic M , et al. 2014
PROZ protein Z, vitamin K-dependent plasma glycoprotein 8858 P22891 IP; LC-MS/MS
Huttlin EL , et al. 2015
RREB1 ras responsive element binding protein 1 6239 Q92766 ChIP-Seq
Vitezic M , et al. 2014
THSD4 Thrombospondin type-1 domain-containing protein 4 79875 Q6ZMP0 IP; LC-MS/MS
Huttlin EL , et al. 2015
APC adenomatous polyposis coli 324 P25054 HITS-CLIP
Preitner N , et al. 2014
Fezf2 Fez family zinc finger 2 54713 Q9ESP5 ChIP; ChIP-Seq
Eckler MJ , et al. 2014
FOXH1 forkhead box H1 14106 O88621 IP/WB
Dou C , et al. 2000
FOXO1 forkhead box O1 2308 Q12778 IP/WB
Seoane J , et al. 2004
FOXO4 forkhead box O4 4303 P98177 IP/WB
Seoane J , et al. 2004
MIR9-1 microRNA 9-1 387133 N/A Luciferase reporter assay
Shibata M , et al. 2008
MIR9-2 microRNA 9-2 723967 N/A Luciferase reporter assay
Shibata M , et al. 2008
MIR9-3 microRNA 9-3 723968 N/A Luciferase reporter assay
Shibata M , et al. 2008
Six3.2 transcription factor-like 100144381 B0R222 ChIP
Beccari L , et al. 2011
SMAD1 SMAD family member 1 4086 Q15797 GST
Rodriguez C , et al. 2001
SMAD2 SMAD family member 2 4087 Q15796 GST
Rodriguez C , et al. 2001
SMAD3 SMAD family member 3 4088 P84022 GST
Rodriguez C , et al. 2001
SMAD4 SMAD family member 4 4089 Q13485 GST
Rodriguez C , et al. 2001
SP1 trans-acting transcription factor 1 20683 O89090 ChIP-Seq
Vitezic M , et al. 2014
TLE1 transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) 7088 Q04724 IP/WB; GST; Luciferase reporter assay
Yao J , et al. 2001
TLE3 transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) 7090 Q04726 GST
Yao J , et al. 2001
TLE6 transducin-like enhancer of split 6, homolog of Drosophila E(spl) 114606 Q9WVB3 IP/WB; GST; Luciferase reporter assay
Maral N , et al. 2005
MECP2 methyl CpG binding protein 2 (Rett syndrome) 29386 Q00566 IP/WB
Dastidar SG , et al. 2012
AKT1 v-akt murine thymoma viral oncogene homolog 1 207 P31749 in vivo kinase assay
Regad T , et al. 2007
CSNK1D casein kinase 1, delta 380361 Q5BP74 in vitro kinase assay; in vivo kinase assay
Regad T , et al. 2007
TLE2 transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) 548559 Q5FV99 IP/WB
Roth M , et al. 2010
WNT8B wingless-type MMTV integration site family, member 8b 30144 P51029 ChIP; GFP repoter assay
Danesin C , et al. 2009

HELP
Copyright © 2017 MindSpec, Inc.